Why the study?
Does technetium-99m-Sestamibi imaging identify myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms?
Does technetium-99m-Sestamibi imaging identify myocardium at risk in patients with acute myocardial infarction and nondiagnostic electrocardiograms?
Technetium-99m-Sestamibi imaging can identify significant myocardium at risk in patients with acute MI and nondiagnostic ECGs, potentially guiding early reperfusion therapy.
Answers are grounded in this paper and cite their sources.
Suggests sestamibi imaging identifies at-risk myocardium despite nondiagnostic ECGs; hypothesis-generating, needs prospective validation.
BACKGROUND: Patients who have chest pain without electrocardiographic ST elevation are not candidates for thrombolytic therapy in most clinical trials. This study examined the value of technetium-99m-Sestamibi tomographic imaging to assess myocardial perfusion in patients during chest pain without ST elevation. METHODS AND RESULTS: Tc-99m-Sestamibi was injected in 14 patients who had chest pain without ST elevation, who subsequently developed enzymatic evidence of myocardial infarction within 24 hours. Tomographic imaging was performed 1-6 hours after injection. Thirteen of 14 patients showed significant perfusion defects indicative of acute myocardial infarction consistent with absent perfusion (20 +/- 15% of the left ventricle; range, 2-53%); one patient had normal images. Because of the absence of definitive electrocardiographic changes, only five patients received reperfusion therapy within 6 hours of the onset of chest pain. Regional wall motion abnormalities were present in nine of nine patients undergoing contrast ventriculography and correlated with the location of the Tc-99m-Sestamibi perfusion defect. At the time of subsequent coronary angiography, total arterial occlusion was present in 11 of the 14 patients. The infarct-related artery could be identified in 13 of the 14 patients. In six of these 13 patients, the left circumflex was the infarct-related artery. CONCLUSIONS: Patients who have chest pain without electrocardiographic ST elevation may have arterial occlusion and significant myocardium at risk. Tc-99m-Sestamibi imaging may be of benefit in identifying these patients early so that they can be considered for acute reperfusion therapy.
No takes yet. Share an insight, caveat, or question.
Christian et al. (1991) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: